(CercleFinance.com) – Valneva announces the signing of a new contract with the US Department of Defense (DoD) for the supply of its Ixiaro Japanese encephalitis vaccine, with deliveries of doses expected to begin immediately.
Under this new one-year contract, DoD will purchase vaccines worth a minimum of $32 million and will have the option to purchase additional doses over the next twelve months.
The only Japanese encephalitis vaccine approved by the US FDA, Ixiaro was developed under a collaborative research and development agreement with the Walter Reed Army Institute of Research, a US Army research center.